MedPath

To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking

Phase 3
Completed
Conditions
Impotence
Interventions
Drug: placebo
Registration Number
NCT00547508
Lead Sponsor
Eli Lilly and Company
Brief Summary

Study to see how effective different doses of tadalafil are for getting and keeping an erection when sex is attempted after a certain number of hours.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
485
Inclusion Criteria
  • At least 3 months history of erectile dysfunction (ED)
  • Anticipate a monogamous relationship with a female sexual partner
  • Be able to make minimum required sexual intercourse attempts
  • Abstain from using any other ED treatment
Exclusion Criteria
  • History of other primary sexual disorder
  • Treatment with nitrates
  • Have a penile implant or clinically significant penile deformity
  • History of certain heart problems
  • Do not meet certain lab value reference ranges

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1placeboPlacebo
2placeboPlacebo
4tadalafiltadalafil
3tadalafiltadalafil
6tadalafiltadalafil
5tadalafiltadalafil
Primary Outcome Measures
NameTimeMethod
Prove superiority to placebo by measuring question 3 of the SEP diary6-10 and 24 weeks
Secondary Outcome Measures
NameTimeMethod
Compare effectiveness when patient can freely choose time of sex versus when time of sex attempt is set by the score of question 3 in the SEP diary6-10 and 24 weeks

Trial Locations

Locations (1)

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

🇺🇸

Knoxville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath